Biopharmaceutical News and Research

RSS
Scientists find fast way to manipulate cell's cilia

Scientists find fast way to manipulate cell's cilia

Aravive Biologics demonstrates proof-of-mechanism for AVB-S6-500 in ongoing phase 1 study

Aravive Biologics demonstrates proof-of-mechanism for AVB-S6-500 in ongoing phase 1 study

Accelerator Life Science Partners launches new company to develop novel therapy for seizure disorders

Accelerator Life Science Partners launches new company to develop novel therapy for seizure disorders

PAREXEL appoints Peyton Howell as chief commercial and strategy officer

PAREXEL appoints Peyton Howell as chief commercial and strategy officer

Sartorius Stedim Biotech launches mini bioreactor vessel for ambr 250 high throughput system

Sartorius Stedim Biotech launches mini bioreactor vessel for ambr 250 high throughput system

Sartorius and Penn State partner to advance teaching and research in biotechnology

Sartorius and Penn State partner to advance teaching and research in biotechnology

Sartorius Stedim Biotech selected by ABL Europe to supply single-use process technologies

Sartorius Stedim Biotech selected by ABL Europe to supply single-use process technologies

Sartorius Stedim Biotech unveils new ambr 250ht perfusion system for cell culture process development

Sartorius Stedim Biotech unveils new ambr 250ht perfusion system for cell culture process development

PAREXEL and CHA collaborate to improve early phase clinical development in Korea

PAREXEL and CHA collaborate to improve early phase clinical development in Korea

Sartorius Stedim Biotech introduces new versions of data analytics software solutions

Sartorius Stedim Biotech introduces new versions of data analytics software solutions

MSD and Ferring Pharmaceuticals Complete Largest Ever Clinical Trial in Postpartum Haemorrhage

MSD and Ferring Pharmaceuticals Complete Largest Ever Clinical Trial in Postpartum Haemorrhage

AbbVie and Voyager Therapeutics collaborate to develop new treatments for tauopathies

AbbVie and Voyager Therapeutics collaborate to develop new treatments for tauopathies

PAREXEL launches new service to optimize management of human biological samples

PAREXEL launches new service to optimize management of human biological samples

Abzena selects Sartorius Stedim Biotech as preferred equipment supplier in the U.S

Abzena selects Sartorius Stedim Biotech as preferred equipment supplier in the U.S

UTokyo enters into agreement for developing personalized cancer vaccine

UTokyo enters into agreement for developing personalized cancer vaccine

Postnova Analytics to hold second annual seminar on advanced separation techniques

Postnova Analytics to hold second annual seminar on advanced separation techniques

ASIT biotech’s new article presents clinical results of gp - ASIT+ for treatment of grass pollen-induced rhinitis

ASIT biotech’s new article presents clinical results of gp - ASIT+ for treatment of grass pollen-induced rhinitis

Macrophage nanosponges offer promising solution for effectively managing sepsis

Macrophage nanosponges offer promising solution for effectively managing sepsis

TriNetX reveals Natural Language Processing to Better Identify Patients for Clinical Trials

TriNetX reveals Natural Language Processing to Better Identify Patients for Clinical Trials

Clinical study uses genetic testing to match AML patients with new therapies

Clinical study uses genetic testing to match AML patients with new therapies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.